Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 28 entries
Sorted by: Best Match Show Resources per page
Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study.

Molecular medicine (Cambridge, Mass.)

Folkersen L, Brynedal B, Diaz-Gallo LM, Ramsköld D, Shchetynsky K, Westerlind H, Sundström Y, Schepis D, Hensvold A, Vivar N, Eloranta ML, Rönnblom L, Brunak S, Malmström V, Catrina A, Moerch UG, Klareskog L, Padyukov L, Berg L.
PMID: 27532898
Mol Med. 2016 Sep;22:322-328. doi: 10.2119/molmed.2016.00078. Epub 2016 Aug 15.

OBJECTIVE: In rheumatoid arthritis (RA) several recent efforts have sought to discover means of predicting which patients would benefit from treatment. However, results have been discrepant with few successful replications. Our objective was to build a biobank with DNA,...

Cite
Folkersen L, Brynedal B, Diaz-Gallo LM, et al. Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study. Mol Med. 2016;22:322-328doi: 10.2119/molmed.2016.00078.
Folkersen, L., Brynedal, B., Diaz-Gallo, L. M., Ramsköld, D., Shchetynsky, K., Westerlind, H., Sundström, Y., Schepis, D., Hensvold, A., Vivar, N., Eloranta, M. L., Rönnblom, L., Brunak, S., Malmström, V., Catrina, A., Moerch, U. G., Klareskog, L., Padyukov, L., & Berg, L. (2016). Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study. Molecular medicine (Cambridge, Mass.), 22322-328. https://doi.org/10.2119/molmed.2016.00078
Folkersen, Lasse, et al. "Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study." Molecular medicine (Cambridge, Mass.) vol. 22 (2016): 322-328. doi: https://doi.org/10.2119/molmed.2016.00078
Folkersen L, Brynedal B, Diaz-Gallo LM, Ramsköld D, Shchetynsky K, Westerlind H, Sundström Y, Schepis D, Hensvold A, Vivar N, Eloranta ML, Rönnblom L, Brunak S, Malmström V, Catrina A, Moerch UG, Klareskog L, Padyukov L, Berg L. Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE study. Mol Med. 2016 Sep;22:322-328. doi: 10.2119/molmed.2016.00078. Epub 2016 Aug 15. PMID: 27532898; PMCID: PMC5023516.
Copy Download .nbib Format: NLM
Arthritis in ducks. II. Condemnation rate, economic significance and possible preventive measures.

Avian pathology : journal of the W.V.P.A

Bisgaard M, Folkersen JC, Høg C.
PMID: 18770146
Avian Pathol. 1981 Jul;10(3):321-7. doi: 10.1080/03079458108418481.

During the period 1959 to 1968 0.4% of ducks slaughtered in Denmark were condemned because they had arthritis. The condemnation rate due to arthritis decreased 2 years after compulsory measures to control salmonella infections were introduced and in the...

Cite
Bisgaard M, Folkersen JC, Høg C. Arthritis in ducks. II. Condemnation rate, economic significance and possible preventive measures. Avian Pathol. 1981;10(3):321-7doi: 10.1080/03079458108418481.
Bisgaard, M., Folkersen, J. C., & Høg, C. (1981). Arthritis in ducks. II. Condemnation rate, economic significance and possible preventive measures. Avian pathology : journal of the W.V.P.A, 10(3), 321-7. https://doi.org/10.1080/03079458108418481
Bisgaard, M, et al. "Arthritis in ducks. II. Condemnation rate, economic significance and possible preventive measures." Avian pathology : journal of the W.V.P.A vol. 10,3 (1981): 321-7. doi: https://doi.org/10.1080/03079458108418481
Bisgaard M, Folkersen JC, Høg C. Arthritis in ducks. II. Condemnation rate, economic significance and possible preventive measures. Avian Pathol. 1981 Jul;10(3):321-7. doi: 10.1080/03079458108418481. PMID: 18770146.
Copy Download .nbib Format: NLM
Quantifying the hydrological impact of simulated changes in land use on peak discharge in a small catchment.

The Science of the total environment

Kalantari Z, Lyon SW, Folkeson L, French HK, Stolte J, Jansson PE, Sassner M.
PMID: 23973540
Sci Total Environ. 2014 Jan 01;466:741-54. doi: 10.1016/j.scitotenv.2013.07.047. Epub 2013 Aug 25.

A physically-based, distributed hydrological model (MIKE SHE) was used to quantify overland runoff in response to four extreme rain events and four types of simulated land use measure in a catchment in Norway. The current land use in the...

Cite
Kalantari Z, Lyon SW, Folkeson L, et al. Quantifying the hydrological impact of simulated changes in land use on peak discharge in a small catchment. Sci Total Environ. 2013;466:741-54doi: 10.1016/j.scitotenv.2013.07.047.
Kalantari, Z., Lyon, S. W., Folkeson, L., French, H. K., Stolte, J., Jansson, P. E., & Sassner, M. (2014). Quantifying the hydrological impact of simulated changes in land use on peak discharge in a small catchment. The Science of the total environment, 466741-54. https://doi.org/10.1016/j.scitotenv.2013.07.047
Kalantari, Zahra, et al. "Quantifying the hydrological impact of simulated changes in land use on peak discharge in a small catchment." The Science of the total environment vol. 466 (2014): 741-54. doi: https://doi.org/10.1016/j.scitotenv.2013.07.047
Kalantari Z, Lyon SW, Folkeson L, French HK, Stolte J, Jansson PE, Sassner M. Quantifying the hydrological impact of simulated changes in land use on peak discharge in a small catchment. Sci Total Environ. 2014 Jan 01;466:741-54. doi: 10.1016/j.scitotenv.2013.07.047. Epub 2013 Aug 25. PMID: 23973540.
Copy Download .nbib Format: NLM
Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19.

medRxiv : the preprint server for health sciences

Klaric L, Gisby JS, Papadaki A, Muckian MD, Macdonald-Dunlop E, Zhao JH, Tokolyi A, Persyn E, Pairo-Castineira E, Morris AP, Kalnapenkis A, Richmond A, Landini A, Hedman ÅK, Prins B, Zanetti D, Wheeler E, Kooperberg C, Yao C, Petrie JR, Fu J, Folkersen L, Walker M, Magnusson M, Eriksson N, Mattsson-Carlgren N, Timmers PRHJ, Hwang SJ, Enroth S, Gustafsson S, Vosa U, Chen Y, Siegbahn A, Reiner A, Johansson Å, Thorand B, Gigante B, Hayward C, Herder C, Gieger C, Langenberg C, Levy D, Zhernakova DV, Smith JG, Campbell H, Sundstrom J, Danesh J, Michaëlsson K, Suhre K, Lind L, Wallentin L, Padyukov L, Landén M, Wareham NJ, Göteson A, Hansson O, Eriksson P, Strawbridge RJ, Assimes TL, Esko T, Gyllensten U, Baillie JK, Paul DS, Joshi PK, Butterworth AS, Mälarstig A, Pirastu N, Wilson JF, Peters JE.
PMID: 33851187
medRxiv. 2021 Apr 07; doi: 10.1101/2021.04.01.21254789.

Severe COVID-19 is characterised by immunopathology and epithelial injury. Proteomic studies have identified circulating proteins that are biomarkers of severe COVID-19, but cannot distinguish correlation from causation. To address this, we performed Mendelian randomisation (MR) to identify proteins that...

Cite
Klaric L, Gisby JS, Papadaki A, et al. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. medRxiv. 2021;doi: 10.1101/2021.04.01.21254789.
Klaric, L., Gisby, J. S., Papadaki, A., Muckian, M. D., Macdonald-Dunlop, E., Zhao, J. H., Tokolyi, A., Persyn, E., Pairo-Castineira, E., Morris, A. P., Kalnapenkis, A., Richmond, A., Landini, A., Hedman, �. �. K., Prins, B., Zanetti, D., Wheeler, E., Kooperberg, C., Yao, C., Petrie, J. R., Fu, J., Folkersen, L., Walker, M., Magnusson, M., Eriksson, N., Mattsson-Carlgren, N., Timmers, P. R. H. J., Hwang, S. J., Enroth, S., Gustafsson, S., Vosa, U., Chen, Y., Siegbahn, A., Reiner, A., Johansson, �. �., Thorand, B., Gigante, B., Hayward, C., Herder, C., Gieger, C., Langenberg, C., Levy, D., Zhernakova, D. V., Smith, J. G., Campbell, H., Sundstrom, J., Danesh, J., Michaëlsson, K., Suhre, K., Lind, L., Wallentin, L., Padyukov, L., Landén, M., Wareham, N. J., Göteson, A., Hansson, O., Eriksson, P., Strawbridge, R. J., Assimes, T. L., Esko, T., Gyllensten, U., Baillie, J. K., Paul, D. S., Joshi, P. K., Butterworth, A. S., Mälarstig, A., Pirastu, N., Wilson, J. F., & Peters, J. E. (2021). Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.04.01.21254789
Klaric, Lucija, et al. "Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.04.01.21254789
Klaric L, Gisby JS, Papadaki A, Muckian MD, Macdonald-Dunlop E, Zhao JH, Tokolyi A, Persyn E, Pairo-Castineira E, Morris AP, Kalnapenkis A, Richmond A, Landini A, Hedman ÅK, Prins B, Zanetti D, Wheeler E, Kooperberg C, Yao C, Petrie JR, Fu J, Folkersen L, Walker M, Magnusson M, Eriksson N, Mattsson-Carlgren N, Timmers PRHJ, Hwang SJ, Enroth S, Gustafsson S, Vosa U, Chen Y, Siegbahn A, Reiner A, Johansson Å, Thorand B, Gigante B, Hayward C, Herder C, Gieger C, Langenberg C, Levy D, Zhernakova DV, Smith JG, Campbell H, Sundstrom J, Danesh J, Michaëlsson K, Suhre K, Lind L, Wallentin L, Padyukov L, Landén M, Wareham NJ, Göteson A, Hansson O, Eriksson P, Strawbridge RJ, Assimes TL, Esko T, Gyllensten U, Baillie JK, Paul DS, Joshi PK, Butterworth AS, Mälarstig A, Pirastu N, Wilson JF, Peters JE. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. medRxiv. 2021 Apr 07; doi: 10.1101/2021.04.01.21254789. PMID: 33851187; PMCID: PMC8043484.
Copy Download .nbib Format: NLM
Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?.

European journal of human genetics : EJHG

Peck L, Borle K, Folkersen L, Austin J.
PMID: 34276054
Eur J Hum Genet. 2021 Jul 19; doi: 10.1038/s41431-021-00929-3. Epub 2021 Jul 19.

We sought to explore individuals' motivations for using their direct-to-consumer genetic testing data to generate polygenic risk scores (PRSs) using a not-for-profit third-party tool, and to assess understanding of, and reaction to their results. Using a cross-sectional design, users...

Cite
Peck L, Borle K, Folkersen L, et al. Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?. Eur J Hum Genet. 2021;doi: 10.1038/s41431-021-00929-3.
Peck, L., Borle, K., Folkersen, L., & Austin, J. (2021). Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?. European journal of human genetics : EJHG, . https://doi.org/10.1038/s41431-021-00929-3
Peck, Larissa, et al. "Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?." European journal of human genetics : EJHG vol. (2021). doi: https://doi.org/10.1038/s41431-021-00929-3
Peck L, Borle K, Folkersen L, Austin J. Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results?. Eur J Hum Genet. 2021 Jul 19; doi: 10.1038/s41431-021-00929-3. Epub 2021 Jul 19. PMID: 34276054.
Copy Download .nbib Format: NLM
A tool for translating polygenic scores onto the absolute scale using summary statistics.

European journal of human genetics : EJHG

Pain O, Gillett AC, Austin JC, Folkersen L, Lewis CM.
PMID: 34983942
Eur J Hum Genet. 2022 Jan 04; doi: 10.1038/s41431-021-01028-z. Epub 2022 Jan 04.

There is growing interest in the clinical application of polygenic scores as their predictive utility increases for a range of health-related phenotypes. However, providing polygenic score predictions on the absolute scale is an important step for their safe interpretation....

Cite
Pain O, Gillett AC, Austin JC, et al. A tool for translating polygenic scores onto the absolute scale using summary statistics. Eur J Hum Genet. 2022;doi: 10.1038/s41431-021-01028-z.
Pain, O., Gillett, A. C., Austin, J. C., Folkersen, L., & Lewis, C. M. (2022). A tool for translating polygenic scores onto the absolute scale using summary statistics. European journal of human genetics : EJHG, . https://doi.org/10.1038/s41431-021-01028-z
Pain, Oliver, et al. "A tool for translating polygenic scores onto the absolute scale using summary statistics." European journal of human genetics : EJHG vol. (2022). doi: https://doi.org/10.1038/s41431-021-01028-z
Pain O, Gillett AC, Austin JC, Folkersen L, Lewis CM. A tool for translating polygenic scores onto the absolute scale using summary statistics. Eur J Hum Genet. 2022 Jan 04; doi: 10.1038/s41431-021-01028-z. Epub 2022 Jan 04. PMID: 34983942.
Copy Download .nbib Format: NLM
Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures.

Journal of thoracic disease

Kronborg-White S, Sritharan SS, Madsen LB, Folkersen B, Voldby N, Poletti V, Rasmussen TR, Bendstrup E.
PMID: 33841938
J Thorac Dis. 2021 Mar;13(3):1455-1465. doi: 10.21037/jtd-20-2431.

BACKGROUND: Transbronchial cryobiopsies has become increasingly used in the diagnostic workup in patients suspected of having interstitial lung disease. The procedure is associated with less complications, morbidity and mortality compared to surgical lung biopsies although with a diagnostic yield...

Cite
Kronborg-White S, Sritharan SS, Madsen LB, et al. Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures. J Thorac Dis. 2021;13(3):1455-1465doi: 10.21037/jtd-20-2431.
Kronborg-White, S., Sritharan, S. S., Madsen, L. B., Folkersen, B., Voldby, N., Poletti, V., Rasmussen, T. R., & Bendstrup, E. (2021). Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures. Journal of thoracic disease, 13(3), 1455-1465. https://doi.org/10.21037/jtd-20-2431
Kronborg-White, Sissel, et al. "Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures." Journal of thoracic disease vol. 13,3 (2021): 1455-1465. doi: https://doi.org/10.21037/jtd-20-2431
Kronborg-White S, Sritharan SS, Madsen LB, Folkersen B, Voldby N, Poletti V, Rasmussen TR, Bendstrup E. Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures. J Thorac Dis. 2021 Mar;13(3):1455-1465. doi: 10.21037/jtd-20-2431. PMID: 33841938; PMCID: PMC8024861.
Copy Download .nbib Format: NLM
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man.

Frontiers in pharmacology

Bentzen BH, Bomholtz SH, Simó-Vicens R, Folkersen L, Abildgaard L, Speerschneider T, Muthukumarasamy KM, Edvardsson N, Sørensen US, Grunnet M, Diness JG.
PMID: 32477117
Front Pharmacol. 2020 May 06;11:610. doi: 10.3389/fphar.2020.00610. eCollection 2020.

AIMS: Small conductance CaMETHODS AND RESULTS: Whole-cell and inside-out patch-clamp recordings of heterologously expressed KCONCLUSIONS: AP30663 is a novel negative allosteric modulator of K

Cite
Bentzen BH, Bomholtz SH, Simó-Vicens R, et al. Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man. Front Pharmacol. 2020;11:610doi: 10.3389/fphar.2020.00610.
Bentzen, B. H., Bomholtz, S. H., Simó-Vicens, R., Folkersen, L., Abildgaard, L., Speerschneider, T., Muthukumarasamy, K. M., Edvardsson, N., Sørensen, U. S., Grunnet, M., & Diness, J. G. (2020). Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man. Frontiers in pharmacology, 11610. https://doi.org/10.3389/fphar.2020.00610
Bentzen, Bo Hjorth, et al. "Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man." Frontiers in pharmacology vol. 11 (2020): 610. doi: https://doi.org/10.3389/fphar.2020.00610
Bentzen BH, Bomholtz SH, Simó-Vicens R, Folkersen L, Abildgaard L, Speerschneider T, Muthukumarasamy KM, Edvardsson N, Sørensen US, Grunnet M, Diness JG. Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man. Front Pharmacol. 2020 May 06;11:610. doi: 10.3389/fphar.2020.00610. eCollection 2020. PMID: 32477117; PMCID: PMC7232560.
Copy Download .nbib Format: NLM
Novel .

Case reports in genetics

Wang X, Wu Y, Cui Y, Wang N, Folkersen L, Wang Y.
PMID: 30105108
Case Rep Genet. 2018 Jul 16;2018:8090797. doi: 10.1155/2018/8090797. eCollection 2018.

Limb girdle muscular dystrophies (LGMDs) are a heterogeneous group of genetic myopathies leading primarily to proximal muscle weakness. It is caused by mutations at over 50 known genetic loci typically from mutations in genes encoding constituents of the sarcolemmal...

Cite
Wang X, Wu Y, Cui Y, et al. Novel . Case Rep Genet. 2018;2018:8090797doi: 10.1155/2018/8090797.
Wang, X., Wu, Y., Cui, Y., Wang, N., Folkersen, L., & Wang, Y. (2018). Novel . Case reports in genetics, 20188090797. https://doi.org/10.1155/2018/8090797
Wang, Xike, et al. "Novel ." Case reports in genetics vol. 2018 (2018): 8090797. doi: https://doi.org/10.1155/2018/8090797
Wang X, Wu Y, Cui Y, Wang N, Folkersen L, Wang Y. Novel . Case Rep Genet. 2018 Jul 16;2018:8090797. doi: 10.1155/2018/8090797. eCollection 2018. PMID: 30105108; PMCID: PMC6076900.
Copy Download .nbib Format: NLM
Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations.

Translational oncology

Sandfeld-Paulsen B, Folkersen BH, Rasmussen TR, Meldgaard P, Sorensen BS.
PMID: 27567953
Transl Oncol. 2016 Aug;9(4):306-12. doi: 10.1016/j.tranon.2016.05.002.

OBJECTIVES: Contradicting results have been demonstrated for the expression of the epidermal growth factor receptor (EGFR) as a prognostic marker in non-small cell lung cancer (NSCLC). The complexity of the EGF system with four interacting receptors and more than...

Cite
Sandfeld-Paulsen B, Folkersen BH, Rasmussen TR, et al. Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Transl Oncol. 2016;9(4):306-12doi: 10.1016/j.tranon.2016.05.002.
Sandfeld-Paulsen, B., Folkersen, B. H., Rasmussen, T. R., Meldgaard, P., & Sorensen, B. S. (2016). Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Translational oncology, 9(4), 306-12. https://doi.org/10.1016/j.tranon.2016.05.002
Sandfeld-Paulsen, Birgitte, et al. "Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations." Translational oncology vol. 9,4 (2016): 306-12. doi: https://doi.org/10.1016/j.tranon.2016.05.002
Sandfeld-Paulsen B, Folkersen BH, Rasmussen TR, Meldgaard P, Sorensen BS. Gene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations. Transl Oncol. 2016 Aug;9(4):306-12. doi: 10.1016/j.tranon.2016.05.002. PMID: 27567953; PMCID: PMC5006812.
Copy Download .nbib Format: NLM
Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction.

Journal of internal medicine

Tengbom J, Cederström S, Verouhis D, Böhm F, Eriksson P, Folkersen L, Gabrielsen A, Jernberg T, Lundman P, Persson J, Saleh N, Settergren M, Sörensson P, Tratsiakovich Y, Tornvall P, Jung C, Pernow J.
PMID: 34237174
J Intern Med. 2021 Nov;290(5):1061-1070. doi: 10.1111/joim.13358. Epub 2021 Aug 23.

BACKGROUND: The mechanisms underlying rupture of a coronary atherosclerotic plaque and development of myocardial ischemia-reperfusion injury in ST-elevation myocardial infarction (STEMI) remain unresolved. Increased arginase 1 activity leads to reduced nitric oxide (NO) production and increased formation of reactive...

Cite
Tengbom J, Cederström S, Verouhis D, et al. Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction. J Intern Med. 2021;290(5):1061-1070doi: 10.1111/joim.13358.
Tengbom, J., Cederström, S., Verouhis, D., Böhm, F., Eriksson, P., Folkersen, L., Gabrielsen, A., Jernberg, T., Lundman, P., Persson, J., Saleh, N., Settergren, M., Sörensson, P., Tratsiakovich, Y., Tornvall, P., Jung, C., & Pernow, J. (2021). Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction. Journal of internal medicine, 290(5), 1061-1070. https://doi.org/10.1111/joim.13358
Tengbom, John, et al. "Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction." Journal of internal medicine vol. 290,5 (2021): 1061-1070. doi: https://doi.org/10.1111/joim.13358
Tengbom J, Cederström S, Verouhis D, Böhm F, Eriksson P, Folkersen L, Gabrielsen A, Jernberg T, Lundman P, Persson J, Saleh N, Settergren M, Sörensson P, Tratsiakovich Y, Tornvall P, Jung C, Pernow J. Arginase 1 is upregulated at admission in patients with ST-elevation myocardial infarction. J Intern Med. 2021 Nov;290(5):1061-1070. doi: 10.1111/joim.13358. Epub 2021 Aug 23. PMID: 34237174.
Copy Download .nbib Format: NLM
Imputed gene expression risk scores: a functionally informed component of polygenic risk.

Human molecular genetics

Pain O, Glanville KP, Hagenaars S, Selzam S, Fürtjes A, Coleman JRI, Rimfeld K, Breen G, Folkersen L, Lewis CM.
PMID: 33611520
Hum Mol Genet. 2021 May 17;30(8):727-738. doi: 10.1093/hmg/ddab053.

Integration of functional genomic annotations when estimating polygenic risk scores (PRS) can provide insight into aetiology and improve risk prediction. This study explores the predictive utility of gene expression risk scores (GeRS), calculated using imputed gene expression and transcriptome-wide...

Cite
Pain O, Glanville KP, Hagenaars S, et al. Imputed gene expression risk scores: a functionally informed component of polygenic risk. Hum Mol Genet. 2021;30(8):727-738doi: 10.1093/hmg/ddab053.
Pain, O., Glanville, K. P., Hagenaars, S., Selzam, S., Fürtjes, A., Coleman, J. R. I., Rimfeld, K., Breen, G., Folkersen, L., & Lewis, C. M. (2021). Imputed gene expression risk scores: a functionally informed component of polygenic risk. Human molecular genetics, 30(8), 727-738. https://doi.org/10.1093/hmg/ddab053
Pain, Oliver, et al. "Imputed gene expression risk scores: a functionally informed component of polygenic risk." Human molecular genetics vol. 30,8 (2021): 727-738. doi: https://doi.org/10.1093/hmg/ddab053
Pain O, Glanville KP, Hagenaars S, Selzam S, Fürtjes A, Coleman JRI, Rimfeld K, Breen G, Folkersen L, Lewis CM. Imputed gene expression risk scores: a functionally informed component of polygenic risk. Hum Mol Genet. 2021 May 17;30(8):727-738. doi: 10.1093/hmg/ddab053. PMID: 33611520; PMCID: PMC8127405.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 28 entries